Camarillo,CA (PRWEB) March 21, 2013
Interlink Electronics, Inc. (OTC: LINK) announced today the integration of their FSR® 402 sensor in Introtek’s PRO Occlusion Detector, a passive non-invasive, free-entry sensor designed for medical, laboratory, pharmaceutical and packaging applications.
Interlink Electronics’ FSR ® 402 is now built into Introtek’s PRO Occlusion Detector, a non-invasive, free-entry sensor designed to detect occlusion in soft tubing and produce corresponding output signal for medical devices, clinical laboratories, pharmaceutical manufacturing and automated packaging applications. The PRO Detector was the result of a steadily growing interest in the global community of medical device manufacturers and offers a unique solution to accurately monitor tubing occlusion.
“As a leader in the development of life saving, non-invasive fluid detection devices we were excited to discover Interlinks FSR® 402 sensor,” said Deb Corwin, Introtek’s General Manager. “It was a perfect match for our Pro-Occlusion Detector product. It provided us with a cost effective sensing solution which had the ideal form factor along with the durability characteristics which our customers have come to expect from Introtek products. It allowed us to achieve our design goals of a reliable, free-entry, maintenance free device. We look forward to a long partnership with Interlink for these sensing needs.”
FSR® 402 is part of Interlink Electronics FSR® 400 series, the most versatile force sensor technology on the market. FSRs® are robust polymer thick film (PTF) two-wire devices that exhibit a decrease in resistance with increase in the force applied to the surface of the sensor. This force is optimized for use in human touch control of electronic devices in diverse applications such as medical systems, electronics, automotive, industrial control and robotics. FSR® 400 sensors are cost effective, ultra thin, robust, simple & easy to integrate into a wide range of user interface and data capture solutions.
“We are delighted to be designed-in to Introtek’s occlusion sensing product,” said Steven N. Bronson, Interlink’s Chief Executive Officer. “We have a long history of working with technology innovators like Introtek to provide innovative sensing solutions for the medical device market.”
Interlink Electronics is a global leader in the design of patented Force-Sensing Resistor (FSR®) technology. For over 28 years, Interlink Electronics’ solutions have focused on handheld user input, menu navigation, cursor control, & other intuitive interface technologies for the world's top electronics manufacturers. For more information on FSR® 400 series go to: http://www.interlinkelectronics.com/products.php. For more information on Introtek’s PRO Occlusion Detector go to http://www.introtek.com/PDFs/1/PRO-10.2.pdf
About Interlink Electronics, Inc.
Interlink Electronics, Inc. (OTC: LINK) is a sensor technology company and one of the world’s leading innovators of intuitive interface design. With numerous patents around the world protecting its technologies and products, Interlink Electronics serves a world-class customer-base from its corporate headquarters in Camarillo, California and offices in Japan, Hong Kong and China. For more information, see http://www.interlinkelectronics.com.
This release contains forward-looking statements that involve a number of risks and uncertainties. The following are among the factors that could cause actual results to differ materially from the forward-looking statements: historical losses and negative cash flow, the success of business divestitures and acquisitions, the ownership of the majority of our stock by a small group of investors, our success in predicting new markets and the acceptance of our new products, efficient management of our infrastructure, the pace of technological developments and industry standards evolution and their effect on our target product and market choices, the effect of outsourcing technology development, changes in the ordering patterns of our customers, a decrease in the quality and/or reliability of our products, protection of our proprietary intellectual property, competition by alternative sophisticated as well as generic products, pending litigation against Interlink, historical weaknesses in internal controls over financial accounting, the continued availability at competitive prices of raw materials for our products, disruptions in our manufacturing facilities, risks of international sales and operations including fluctuations in exchange rates, compliance with regulatory requirements applicable to our manufacturing operations, and customer concentrations. The forward-looking statements contained in this release should be considered in light of these risk factors.
For Investor Relations:
Steven N. Bronson +1 805-484-8855 ext.112
For information on FSR® 400 series:
Paul Kelley, +1 805.436.0271
Global Sales Manager